UnknownNot Applicable

The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Israel50 participantsStarted 2016-05

Plain-language summary

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Who can participate

Age range5 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * New diagnosis of attention deficit hyperactivity disorder * History of primary nocturnal enuresis * Normal neurological examination Exclusion Criteria: * Anatomical abnormality of the genitourinary system * Concommitant treatment, pharmacological/behavioral for enuresis * Concommitant diurnal enuresis

What they're measuring

A reduction in nocturnal enuresis frequency

Timeframe: 6 weeks

Trial details

NCT IDNCT02699528

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-04

Contact for this trial

Florence Katz, BA

972-9-7471803 florence.katz@clalit.org.il

View on ClinicalTrials.gov More Attention Deficit Hyperactivity Disorder trials